Perioperative management for liver resection to prevent posthepatectomy liver failure
Evidence-based care for liver resection focuses on (1) minimizing ischemia–reperfusion injury and hepatic congestion during transection and vascular occlusion, (2) limiting blood loss and transfusion, (3) using restrictive or goal-directed fluid strategies to reduce central venous pressure (CVP)-driven bleeding and venous backflow, and (4) preventing inadequate future liver remnant (FLR) function with preoperative FLR assessment and planned inflow/outflow strategies when FLR is borderline. [1]
Anesthesia technique optimizing hepatic perfusion and minimizing hepatic injury
General anesthesia is used with continuous invasive hemodynamic monitoring. [1]
Restrictive hemodynamic management is recommended during parenchymal transection with the goal of reducing hepatic venous congestion. [2]
Controlled low-CVP strategies are commonly paired with intermittent inflow occlusion when needed to limit bleeding. [3]
Propofol-based anesthesia has shown improved postoperative liver biochemistry versus sevoflurane in a randomized trial of hepatectomy performed with Pringle maneuver. [4]
Fluid therapy during liver transection
Restrictive fluid strategies are recommended during the dissection and transection phases to avoid elevated CVP, increased retrograde liver blood flow, and venous bleeding. [2]
Goal-directed fluid therapy (GDT) approaches have shown feasibility and biologic targeting in major liver resection, using individualized optimization of fluid responsiveness. [5]
In a randomized controlled trial using stroke-volume-variation–guided GDT for liver resection, the GDT arm received less fluid during the intraoperative postoperative-resection phase while achieving protocolized resuscitation goals. [6]
In a randomized trial comparing absolute fluid restriction with a relative volume-redistribution strategy under low-CVP conditions, reduced blood loss and reduced transfusion rate were observed in the Pringle maneuver arms. [7]
Vascular control methods to limit blood loss while reducing ischemia–reperfusion injury
Inflow control (portal triad inflow occlusion)
Intermittent Pringle maneuver is used to reduce blood loss, but routine benefit over no Pringle for postoperative outcomes has been questioned in randomized evidence. [8]
Perioperative planning should balance hemostatic goals with ischemia–reperfusion exposure because ischaemia-reperfusion injury is a recognized driver of PHLF risk. [1]
Ischemia–reperfusion modulation strategies
Ischemic preparation and ischemic preconditioning strategies are described as approaches intended to reduce ischemia–reperfusion injury signaling during resection. [1]
Randomized data have evaluated combined use of Pringle maneuver with ischemic preconditioning, showing physiologic effects on hemodynamic stability during elective hepatectomy. [9]
Outflow control and total vascular exclusion
Total vascular exclusion (TVE) is associated with substantial ischemia–reperfusion exposure and is therefore treated as a higher-risk option in prevention frameworks for PHLF. [1]
Strategies to prevent posthepatectomy liver failure (PHLF)
PHLF prevention is guided by minimizing continued parenchymal injury after resection while supporting regeneration of an adequate FLR. [1]
Patient and preoperative risk optimization
Preoperative risk assessment is recommended to identify targets that increase susceptibility to PHLF, including small-for-size physiology, liver parenchymal injury from prior therapies, and impaired baseline liver function. [1]
FLR planning and volume/flow modulation
Borderline FLR scenarios are managed with planned volume/flow modulation strategies to reduce the probability of regeneration failure, including staged resection and portal vein embolization approaches. [10]
Intraoperative strategies that reduce PHLF triggers
Surgical strategies emphasize minimizing blood loss, avoiding unnecessary dissection of the hepatoduodenal ligament, and limiting transfusion. [1]
Parenchymal transection is performed under low-CVP conditions when feasible to reduce venous backflow and bleeding. [1]
Intermittent inflow occlusion and ischemic preparation are used as ischemia–reperfusion modulation strategies rather than prolonged continuous clamping. [1]
Hypothermic liver protection, two-stage resection in select patients, and avoidance of prolonged inflow/outflow occlusion are listed as additional intraoperative prevention strategies. [1]
Monotherapy versus combination perioperative strategies
PHLF prevention is not a single-measure intervention. [1]
Effective prevention frameworks combine:
- Restrictive or goal-directed fluid strategies to limit CVP elevation during transection. [2]
- Low-CVP surgical conditions with selective inflow occlusion for hemostasis. [7]
- Ischemia–reperfusion modulation strategies when inflow occlusion is necessary. [1]
- Blood-loss minimization and transfusion avoidance to reduce injury amplification. [1]
Initiation thresholds and clinical triggers for escalation of prevention
In prevention frameworks, escalation is prompted by intraoperative and operative risk markers associated with higher PHLF risk. [1]
Risk triggers include:
- Intraoperative bleeding exceeding 1200 mL. [1]
- Massive transfusion. [1]
- Prolonged application of inflow occlusion or total vascular exclusion. [1]
- Operating time exceeding 240 minutes. [1]
- Remnant liver volume below 25%. [1]
Common pitfalls to avoid
PHLF prevention frameworks emphasize avoidance of prolonged ischemia–reperfusion exposure and prevention of ongoing parenchymal damage after resection. [1]
Key pitfalls include:
- Excessive blood loss and massive transfusion. [1]
- Failure to control CVP during transection, contributing to hepatic venous congestion and bleeding. [2]
- Prolonged or unnecessary vascular exclusion maneuvers, including extended Pringle or TVE exposure. [1]
- Prolonged operative times that amplify injury and delay functional recovery. [1]
Targets of perioperative physiologic management
Targets are framed around maintaining a low-hepatic-congestion state and limiting fluid overload during transection. [2]
Implementation is typically protocolized as:
- Low-CVP conditions during parenchymal transection. [1]
- Restrictive fluid balance during dissection and transection phases. [2]
- Goal-directed or stroke-volume-variation–guided resuscitation during phases when fluid responsiveness evaluation is needed. [6]
PHLF prevention also requires structural targets in operative planning, including ensuring adequate FLR and applying volume/flow modulation strategies when FLR is predicted to be insufficient. [10]